STOCK TITAN

Israeli Court Greenlights Xylo Tech's Take-Private Plan, Nasdaq Exit Looms

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

L.I.A. Pure Capital Ltd. and CEO Kfir Silberman have filed Amendment No. 5 to their Schedule 13D regarding Xylo Technologies. The filing discloses significant developments in their ownership position and a major corporate transaction:

Key details:

  • The reporting persons currently own 2,980,000 ordinary shares (74,500 ADSs), representing 5.81% of outstanding shares
  • On June 22, 2025, the Tel Aviv district court approved an arrangement for Pure Capital to acquire all remaining shares of Xylo Technologies
  • The arrangement must be completed within 180 days of court approval
  • Upon completion, Xylo will become a wholly-owned subsidiary of Pure Capital
  • The company will subsequently delist from Nasdaq and terminate its public company obligations

Recent transactions include purchases of 1,000 ADSs at $5.004 on June 18 and 1,000 ADSs at $4.986 on June 20, 2025. Total investment in shares amounts to approximately $314,500.

Positive

  • Court approved arrangement for L.I.A. Pure Capital to acquire all remaining shares of Xylo Technologies, indicating a definitive path to acquisition completion
  • Transaction expected to be completed within 180 days of June 22, 2025, providing clear timeline for shareholders

Negative

  • Delisting from Nasdaq and termination of public company status will reduce liquidity for existing shareholders
  • Recent share purchases by L.I.A. Pure Capital at $4.986-$5.004 suggest relatively low acquisition price point





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Includes 2,980,000 ordinary shares underlying 74,500 ADSs held by L.I.A Pure Capital Ltd. (2) Based on 51,241,661 ordinary shares outstanding as of April 17, 2025 (based on the Issuer's Notice and Proxy Statement in connection with the special general meetings, furnished to the Securities and Exchange Commission on April 21, 2025).


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Includes 2,980,000 ordinary shares underlying 74,500 ADSs held by L.I.A Pure Capital Ltd. (2) Based on 51,241,661 ordinary shares outstanding as of April 17, 2025 (based on the Issuer's Notice and Proxy Statement in connection with the special general meetings, furnished to the Securities and Exchange Commission on April 21, 2025).


SCHEDULE 13D


L.I.A. Pure Capital Ltd.
Signature:/s/ Kfir Silberman
Name/Title:Kfir Silberman
Date:06/25/2025
Kfir Silberman
Signature:/s/ Kfir Silberman
Name/Title:Kfir Silberman
Date:06/25/2025

FAQ

How many shares of XYLO does L.I.A. Pure Capital Ltd. own?

L.I.A. Pure Capital Ltd. owns 2,980,000 ordinary shares of XYLO (underlying 74,500 ADSs), representing approximately 5.81% of the company's outstanding shares as of April 17, 2025.

What is the purpose of XYLO's Schedule 13D/A filing from June 28, 2025?

The Schedule 13D/A filing discloses that on June 22, 2025, the Tel Aviv district court approved an arrangement where L.I.A. Pure Capital Ltd. will purchase all remaining XYLO shares it doesn't already own, making XYLO a wholly-owned subsidiary. This will result in XYLO being delisted from Nasdaq and terminating its public company obligations.

What recent transactions did L.I.A. Pure Capital make in XYLO stock?

L.I.A. Pure Capital made two recent purchases of XYLO ADSs: 1,000 ADSs at $5.004 per ADS on June 18, 2025, and 1,000 ADSs at $4.986 per ADS on June 20, 2025.

When will XYLO's privatization arrangement be completed?

According to the filing, the Tel Aviv court has mandated that the privatization arrangement must be consummated within 180 days of June 22, 2025. XYLO expects to complete the arrangement according to previously disclosed terms.

Who controls L.I.A. Pure Capital Ltd.'s investment in XYLO?

Kfir Silberman, an Israeli citizen, controls L.I.A. Pure Capital Ltd.'s investment in XYLO as the company's chief executive officer, sole director, and sole shareholder. He has sole voting and dispositive power over the 2,980,000 shares.
Xylo Technologies

NASDAQ:XYLO

View XYLO Stock Overview

XYLO Rankings

XYLO Latest News

XYLO Latest SEC Filings

XYLO Stock Data

6.49M
1.17M
Medical Devices
Healthcare
Link
Israel
Tel Aviv